首页> 外国专利> Drug for treatment of endometriosis or adenomyosis, and screening method for treatment of endometriosis or adenomyosis

Drug for treatment of endometriosis or adenomyosis, and screening method for treatment of endometriosis or adenomyosis

机译:治疗子宫内膜异位或子宫腺肌病的药物及治疗子宫内膜异位或子宫腺肌病的筛选方法

摘要

To provide a novel medicine for treating endometriosis or uterine adenomyosis using no hormonal therapy, and to provide a screening method of the novel medicine for treating endometriosis or uterine adenomyosis.SOLUTION: Provided are a medicine for treating endometriosis or uterine adenomyosis which contains a MyD88-IRAK4 signal transduction pathway inhibitor, and a screening method of a medicine for treating endometriosis or uterine adenomyosis which uses an activation state of MyD88-IRAK4 signal transduction pathway as an index.SELECTED DRAWING: Figure 4
机译:提供一种无需激素治疗子宫内膜异位或子宫子宫腺肌症的新药,并提供一种筛选该子宫内膜异位或子宫子宫腺肌病的新药的方法。使用MyD88-IRAK4信号转导途径的激活状态作为指标的IRAK4信号转导途径抑制剂和子宫内膜异位或子宫腺肌症药物的筛选方法。选择的附图:图4

著录项

  • 公开/公告号JP2019043949A

    专利类型

  • 公开/公告日2019-03-22

    原文格式PDF

  • 申请/专利权人 HYOGO COLLEGE OF MEDICINE;

    申请/专利号JP20180164658

  • 发明设计人 安田 好文;加藤 徹;善本 知広;

    申请日2018-09-03

  • 分类号A61K45/00;A61K31/4439;A61P15/00;A61P43/00;C07K14/47;C12N9/12;C12Q1/06;G01N33/50;G01N33/15;

  • 国家 JP

  • 入库时间 2022-08-21 12:24:09

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号